Sat.Jun 26, 2021 - Fri.Jul 02, 2021

article thumbnail

BioMarin resubmits haemophilia A gene therapy to the EMA

Pharma Times

Company initially withdrew a marketing authorisation application for the gene therapy last year

146
146
article thumbnail

Blockchain: Ready to revolutionise medicinal cannabis research?

pharmaphorum

Robert Galarza outlines how blockchain technology can be utilised to verify, validate and standardise the efficacy of medical cannabis and other plant based therapies in clinical trials. . The Chinese surgeon Huo Tuo first mixed powdered cannabis with wine to make an anesthetic sometime between 140 and 208 CE. Indeed, the Chinese term for “anesthesia” (mázui ??

Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Trending Sources

article thumbnail

The FDA Should Fully Approve Pfizer and Moderna's Vaccines

NY Times

The Pfizer and Moderna vaccines are safe and effective. Full approval from the F.D.A. will help stop the spread of Covid-19.

Vaccines 117
article thumbnail

Which pharmaceutical companies have the most drug patents in Luxembourg?

Drug Patent Watch

This chart shows the pharmaceutical companies with the most patents in Luxembourg. Patents must be filed in each country (or, in some cases regional patent office) where patent protection is…. The post Which pharmaceutical companies have the most drug patents in Luxembourg? appeared first on DrugPatentWatch - Make Better Decisions.

article thumbnail

Navigating Payroll Compliance: Future-Proofing Payroll in an Evolving Regulatory Landscape

Speaker: Jennifer Hill

Payroll compliance is a cornerstone of business success, yet for small and midsize businesses, it’s becoming increasingly challenging to navigate the ever-evolving landscape of federal, state, and local regulations. Mistakes can lead to costly penalties and operational disruptions, making it essential to adopt advanced solutions that ensure accuracy and efficiency.

article thumbnail

bluebird bio’s sickle cell gene therapy granted MHRA ‘innovation passport’

Pharma Times

Innovation passport designation scheme aims to reduce the time to market for promising treatments

130
130

More Trending

article thumbnail

Formedix launches cloud-based clinical metadata repository

Outsourcing Pharma

The companyâs Ryze technology combines a clinical MDR and study automation platform, designed to accelerate and optimize design and execution of trials.

98
article thumbnail

Johnson & Johnson to Pay New York $230 Million to Settle Opioid Case

NY Times

The settlement agreement came just days before opening arguments in a sweeping trial of several defendants, including the company.

97
article thumbnail

‘Mix and match’ COVID-19 vaccine study yields promising results

Pharma Times

Mixing different vaccines produces a strong immune response against virus, according to researchers

Vaccines 130
article thumbnail

Renal disease: the big picture

pharmaphorum

Renal diseases represent a formidable challenge on public health systems around the world. They are costly in terms of economic burden and quality of life, especially among older patient populations, and are closely linked to other chronic conditions such as cardiovascular disease and diabetes. Joan Perelló and Adam Levy explore the advancement of treatments in the renal space.

Diabetes 105
article thumbnail

From Diagnosis to Delivery: How AI is Revolutionizing the Patient Experience

Speaker: Simran Kaur, Founder & CEO at Tattva Health Inc.

The healthcare landscape is being revolutionized by AI and cutting-edge digital technologies, reshaping how patients receive care and interact with providers. In this webinar led by Simran Kaur, we will explore how AI-driven solutions are enhancing patient communication, improving care quality, and empowering preventive and predictive medicine. You'll also learn how AI is streamlining healthcare processes, helping providers offer more efficient, personalized care and enabling faster, data-driven

article thumbnail

Signify Health partners on decentralized trials for children’s cancer

Outsourcing Pharma

The trial solutions firm is working with Childrenâs Oncology Group to expand in-home research and care options for investigational immune-oncology therapy.

article thumbnail

Training the Next Generation of Indigenous Data Scientists

NY Times

A new workshop explores the right of Indigenous people to govern the collection, ownership and use of their biological and cultural data.

93
article thumbnail

Sanofi plans €400m investment in mRNA vaccines ‘centre of excellence’

Pharma Times

Sanofi is currently collaborating with Translate Bio on a mRNA-based COVID-19 vaccine candidate

Vaccines 130
article thumbnail

Intellia, Regeneron ace first trial with ‘in vivo’ CRISPR drug

pharmaphorum

The first ever clinical data with a CRISPR/Cas9 drug used to edit the genomes of cells within the body has yielded impressive results in patients with ATTR amyloidosis, a life-threatening rare disease. . Preliminary results from a phase 1 trial run by Regeneron and CRISPR specialist Intellia Therapeutics – co-founded by Nobel Prize winner Jennifer Doudna – showed steep reductions in a biomarker of ATTR amyloidosis disease activity with a single dose of the NTLA-2001 drug.

Packaging 105
article thumbnail

Why Every Small Business Needs an HCM Solution: A Comprehensive Guide

Managing HR tasks like payroll, compliance, and employee data can overwhelm small businesses. That’s where a Human Capital Management (HCM) solution comes in. Our eBook, Why Every Small Business Needs an HCM Solution: A Comprehensive Guide , shows how an HCM system automates tedious processes, ensuring your business stays compliant and efficient. You’ll learn how to simplify payroll, eliminate costly errors, and empower your employees with self-service tools.

article thumbnail

New patent for Merck Sharp drug NOXAFIL

Drug Patent Watch

Annual Drug Patent Expirations for NOXAFIL Noxafil is a drug marketed by Merck Sharp Dohme and Schering and is included in three NDAs. It is available from three suppliers. There…. The post New patent for Merck Sharp drug NOXAFIL appeared first on DrugPatentWatch - Make Better Decisions.

75
article thumbnail

An Opioid Case Like No Other: New York vs the Entire Supply Chain

NY Times

New York’s sweeping lawsuit is the first opioid case in which a jury rather than a judge will decide the outcome.

70
article thumbnail

ABPI launches updated Code of Practice

Pharma Times

The new Code has been updated to reflect changes in the pharma environment

130
130
article thumbnail

COVID-19 vaccine development: Safety monitoring continues revolution in RWD

pharmaphorum

From cancer to COVID, real-world data is changing the way we research therapeutics, monitor safety, and collaborate on the development of treatments designed to improve outcomes for patients in need. In today’s feature, Dr. Miruna Sasu lays out how real-world data is evolving in the post COVID-19 vaccine reality. . Only a year after the emergence of COVID-19, a handful of life science companies started publishing data on the encouragingly high efficacy of their vaccine candidates.

Vaccines 103
article thumbnail

Position Your Pharmacy for Expansion

Speaker: Chris Antypas and Josh Halladay

Access to limited distribution drugs and payer contracts are key to pharmacy expansion. But how do you prepare your operations to take the next step? Meaningful data: Collect and share clinical data regarding outcomes, utilization, and more Reporting: Limited distribution models require efficient tracking and reporting systems Workflows: Align workflows with specific pharma and payer contractual requirements For in-depth, expert insights on pharmacy expansion, watch this webinar from Inovalon.

article thumbnail

Which pharmaceutical companies have the most film dosed drugs?

Drug Patent Watch

This chart shows the pharmaceutical companies with the most film dosed drugs. For a different perspective, see the most popular dosage types. The companies with the most film dosed drugs…. The post Which pharmaceutical companies have the most film dosed drugs? appeared first on DrugPatentWatch - Make Better Decisions.

article thumbnail

Quest to Help Diabetic Son Endures With a Different Kind of Giving

NY Times

Sean Doherty set up a private equity-like fund with other parents four years ago. Some investments in research have worked. Some haven’t.

article thumbnail

AZ says MPO inhibitor AZD4831 shows promise in heart failure study

Pharma Times

AZD4831 is being investigated in patients with heart failure with preserved ejection fraction (HFpEF)

127
127
article thumbnail

AZ drug for hard-to-treat heart failure has mixed results in trial

pharmaphorum

AstraZeneca has reported the first phase 2 results with a drug for heart failure with preserved ejection fraction (HFpEF), showing it worked as expected but wasn’t able to provide any clinical benefit to patients. . Daily doses of AZD4831 were able to reduce the activity of myeloperoxidase (MPO), an enzyme linked to tissue and blood vessel damage due to inflammation and scar tissues formation (fibrosis) in models of cardiovascular disease, by 69% after 30 days in the phase 2a SATELLITE stu

article thumbnail

Best Practices to Streamline Compensation Management: A Foundation for Growth

Speaker: Joe Sharpe and James Carlson

Payroll optimization can be one of the most time-consuming and complex factors of small business management. Yet, organizations that crack the code on streamlining employee compensation often discover innovative avenues for growth. With the right strategies in place, outsourcing and streamlining payroll processes can result in substantial time and resource savings.

article thumbnail

Experts to talk rare and orphan diseases, patient experience at webinar

Outsourcing Pharma

On July 7, a group of seasoned industry leaders will offer insights at Rare/orphan diseases, special patient population, a focused, free online event.

59
article thumbnail

New patent expiration for Bausch And drug BESIVANCE

Drug Patent Watch

Annual Drug Patent Expirations for BESIVANCE Besivance is a drug marketed by Bausch And Lomb and is included in one NDA. It is available from two suppliers. There are five…. The post New patent expiration for Bausch And drug BESIVANCE appeared first on DrugPatentWatch - Make Better Decisions.

59
article thumbnail

Jazz Pharma’s blood cancer therapy Rylaze wins US approval

Pharma Times

Rylaze has been specifically developed for patients who have developed hypersensitivity to E.

123
123
article thumbnail

Altimmune ditches nasal COVID vaccine on weak trial data

pharmaphorum

Just a few months after starting clinical trials of its nasal spray vaccine for COVID-19, US biotech Altimmune is abandoning the project, saying that it generated weaker than expected immune responses in a phase 1 trial. . It’s a big disappointment for Altimmune, which said back in February that it was hoping to find a more convenient alternative to injected COVID-19 vaccines – and one which would be stable at room temperature, making distribution and delivery easier.

article thumbnail

Enhance Healthcare Efficiency With Top Payroll & HCM Services

Running a healthcare facility requires precision and care, not just for patients but also for your staff. Our guide, "A Buyer’s Guide to Payroll & HCM Services," helps healthcare providers choose the best provider. Efficient payroll management ensures timely, accurate payments, critical for maintaining staff morale and trust. Compliance support helps navigate complex healthcare regulations and avoid costly fines.